Here’s what you should know:
1. Dr. Feinsod previously served as the company’s product development officer.
2. He succeeds Michael Goldstein, MD, who left the company to pursue other opportunities.
3. Dr. Feinsod holds several ophthalmology-based patents. He has also founded several companies, including Imagen Biotech, a company developing ophthalmology treatments for the unmet needs of those suffering from sight-threatening diseases.
4. Dr. Feinsod will be supported by the company’s clinical team.
More articles on leadership:
North Mississippi Medical Center Ambulatory Surgery Center RN continues full-time career at 81
Surgery Partners appoints Clifford Adlerz interim CEO
ASC leader to know: Don Phalen of Regent Surgical Health
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.